Literature DB >> 1095913

Induction and mutagenesis of prophage lambda in Escherichia coli K12 by metabolites of aflatoxin B1.

A Goze, A Sarsin, Y Moulé, R Devoret.   

Abstract

Like most carcinogens, aflatoxin B1 must be activated by mammalian microsomal enzymes to give rise to coupounds active on bacteria. These compounds act as inducers of E. coli K12 (lambda) at a high efficiency, whereas unmodified aflatoxin B1 has no effect. Moreover, metabolites of aflatoxin B1 have a mutagenic action on phage lambda, as shown by the appearance of clear plaque mutants. We propose the hypothesis that the same derivative is responsible for carcinogenesis of liver cells by aflatoxin B1. Therefore, our system provides a simple way of measuring in vitro, in the same assay, the mutagenic and inducing activities of compounds to which the cells are permeable, thereby detecting potentially carcinogenic agents.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1095913

Source DB:  PubMed          Journal:  Mutat Res        ISSN: 0027-5107            Impact factor:   2.433


  5 in total

1.  Mutation of lambda during prophage induction by nitrosamides.

Authors:  B J Smith
Journal:  Mol Gen Genet       Date:  1976-05-07

Review 2.  Ultraviolet mutagenesis and inducible DNA repair in Escherichia coli.

Authors:  E M Witkin
Journal:  Bacteriol Rev       Date:  1976-12

3.  Conditions for induction of bacteriophage from lysogenic Bacillus megaterium with aflatoxin B1.

Authors:  B L Whittaker; J R Chipley
Journal:  Appl Environ Microbiol       Date:  1979-03       Impact factor: 4.792

4.  Prophage lambda induction of Escherichia coli K12 envA uvrB: a highly sensitive test for potential carcinogens.

Authors:  P Moreau; A Bailone; R Devoret
Journal:  Proc Natl Acad Sci U S A       Date:  1976-10       Impact factor: 11.205

5.  Prophage induction and filamentation in Bacillus thuringiensis caused by the genotoxic mycotoxin aflatoxin B1.

Authors:  Y Auffray; P Boutibonnes
Journal:  Mycopathologia       Date:  1985-09       Impact factor: 2.574

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.